Vision loss

Paraneoplastic Vision Loss Evaluation [Test in Focus]

Andrew McKeon, M,B., B.Ch., M.D., provides an overview of Mayo Clinic Laboratories' new paraneoplastic vision loss evaluation — a test that can help direct a cancer diagnosis and guide treatment. He reviews why this test was developed, when it should be ordered, and how the results can affect patient care.

By Samantha Rossi • February 16, 2021